CD19 and neoplasm: NSG mice were infused with iC9.CAR.CD19 DAUDI cells at day −3 (Figure 4A); after tumor engraftment, the dimerizing drug AP1903 was intraperitoneally administrated from day 0 to day 28 (Figure 4A).